The human brain clears fluid directly into the skull, and poor sleep slows the process down

Brain fluid drains directly into the spongy marrow of the human skull, establishing a physical connection between the nervous system and the immune system. A recent imaging study reveals that this drainage process is slower in older individuals and those experiencing poor sleep or cognitive decline. The research was published in the journal eLife.

Historically, biologists thought the central nervous system was entirely isolated from the rest of the body. A specialized cellular boundary called the blood-brain barrier supposedly prevented immune cells and other substances from entering or leaving the brain. This isolation was thought to protect delicate neural tissue from damaging inflammation. Recent discoveries have challenged this view of the nervous system, revealing that the brain communicates directly with the surrounding bone.

Studies in mice and human tissue have identified tiny physical channels connecting the brain’s outer protective layers directly to the bone marrow inside the skull. The bone marrow is a spongy tissue inside bones that produces blood cells and immune cells. These microscopic channels allow cerebrospinal fluid to exit the brain and interact with the immune cells residing in the skull. Cerebrospinal fluid is the colorless liquid that surrounds and cushions the brain and spinal cord, acting as a waste removal system for the nervous system.

To better understand how this fluid moves in living humans, researchers at Zhejiang University in China organized an imaging study. The research team, led by Ying Zhou, Haidi Jin, and Min Lou, wanted to map exactly where and how fast the fluid travels into the skull. They also wanted to see if medical conditions, sleep quality, and memory might relate to how well this fluid system functions.

The researchers enrolled 87 patients who were already scheduled to receive a spinal tap for various neurological conditions. The medical team injected a contrast agent called gadolinium into the cerebrospinal fluid in the lower back of each patient. Gadolinium shows up brightly on magnetic resonance imaging, or MRI, allowing researchers to track the fluid as it travels up the spine and into the head.

The patients underwent MRI scans before the injection and at three later time points. These follow-up scans occurred at 4.5 hours, 15 hours, and 39 hours after the initial injection. The research team focused their analysis on the bone marrow in three specific areas of the skull. They looked at the top of the head near a major vein called the superior sagittal sinus, the sides of the skull near the lateral fissure, and the base of the skull near the cisterna magna.

To measure the concentration of the contrast agent, the researchers compared the signal in the skull marrow against a reference point in the eyeball. The fluid inside the eye does not absorb the contrast agent, providing a stable baseline. By calculating the ratio between the skull signal and the eye signal, the team could track how much fluid had reached the bone marrow at each time point.

To evaluate health and lifestyle factors, the researchers also administered questionnaires to the participants. They used a standard survey to assess sleep quality over the previous month, looking at factors like sleep duration and nighttime disturbances. One month after the patients left the hospital, researchers evaluated their cognitive performance using a telephone-based test that measures attention, language, memory, and orientation.

The MRI scans showed the contrast agent moving from the cerebrospinal fluid directly into the skull bone marrow. The speed of this fluid movement varied depending on the anatomical region. Fluid reached the bone marrow at the top of the head the fastest. For a majority of the patients, the contrast agent peaked in this top region at the 4.5-hour mark.

Fluid movement into the bone marrow at the base of the skull was much slower. In half of the patients, the contrast agent did not peak in this lower region until 15 hours after the injection. The researchers hypothesize that fluid might travel through alternative pathways between the skull and the brain, speeding up delivery to the top of the head while bypassing other areas.

The researchers then analyzed what biological factors might influence the speed of fluid drainage near the top of the head. They found that older age, high blood pressure, and diabetes all correlated with slower fluid movement into the skull bone marrow. Female patients also showed slower drainage compared to male patients.

The drainage patterns were also linked to signs of systemic inflammation. Patients with slower fluid drainage had higher percentages of neutrophils, but lower percentages of monocytes and lymphocytes, in their blood. Neutrophils and monocytes are types of white blood cells that respond to infections and injuries. This suggests that higher levels of inflammation in the body might restrict the flow of cerebrospinal fluid into the skull marrow.

The patient questionnaires revealed a link between fluid drainage, sleep, and memory. Patients who reported worse sleep quality had slower drainage into the skull bone marrow at the top of the head. Slower drainage also correlated with lower scores on the cognitive telephone test.

Through statistical analysis, the researchers explored whether this drainage system might bridge the known gap between poor sleep and memory problems. Their calculations showed that the speed of fluid drainage accounted for roughly 38 percent of the statistical association between poor sleep and lower cognitive scores. The research team proposed that sleep disturbances might worsen inflammation, which in turn slows down fluid drainage and contributes to cognitive decline.

The study relies on observational data, meaning it cannot prove that slow fluid drainage causes cognitive decline or sleep problems. The statistical links only show that these variables change in tandem. Additionally, the patients in the study all had existing neurological conditions, such as peripheral neuropathy or encephalitis. Without a comparison group of healthy individuals, it remains unknown if these fluid dynamics operate the same way in the general public.

The methods used to measure sleep and cognition also present limitations. The researchers relied on self-reported questionnaires and telephone interviews rather than objective physiological measurements. A clinical sleep study measuring brain waves would provide a more accurate picture of how specific sleep stages relate to fluid movement.

The interpretation of the imaging timeline requires caution. The researchers classified the highest MRI signal at 4.5 hours as an indicator of drainage efficiency. This early time frame might just represent the fluid entering the bone marrow, while the later scans might better reflect the fluid actually washing out of the tissue. Future imaging studies with more frequent scanning intervals will be required to map the exact timeline of fluid entering and exiting the skull.

The study, “Skull Bone Marrow Drainage and Its Associations with Inflammation, Sleep Quality, and Cognitive Performance,” was authored by Ying Zhou, Haidi Jin, Xiao Zhu, Yifei Li, Ziyu Zhou, Xin Huang, Huihong Ke, Mengmeng Fang, Jianzhong Sun, and Min Lou.